AGP Executive Report
Last update: 9 hours agoOpioid Alert: Rhode Island health officials confirmed a powerful synthetic opioid, cychlorphine (N-Propionitrile Chlorphine), has entered the state’s drug supply—sometimes mixed with fentanyl—raising overdose risk; RIDOH says naloxone remains effective. Workplace Health: A new national menopause policy report finds menopause is increasingly becoming an employer compliance and benefits issue, with Rhode Island Sen. Lori Urso co-authoring an update tracking laws and executive actions. Housing Safety: Gov. Dan McKee is expected to sign a bill letting domestic and sexual violence survivors end rental leases early without major penalties, with options like lock changes when staying is safest. Cannabis Governance: The RI Senate confirmed Michelle Reddish as chair of the Cannabis Control Commission, with reappointments also approved as the session wrapped. Legal Fight Over Trans Care Records: A federal judge declined to block DOJ efforts nationwide to obtain trans youth medical records, though the ruling leaves room for further legal challenges. Public Health & Safety: RIDOH continues to post press releases online, while Rhode Island also faces ongoing summer health concerns like tick prevention guidance circulating regionwide. Community & Wellness: A Rhode Island student won a $1 million scholarship to help older adults build tech skills through workshops—aimed at reducing loneliness and bridging generations.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.